Banco Santander S.A. (SAN)
12.15
-0.32 (2.57%)
Upcoming Events
Latest Headlines
Form CERT Banco Santander, S.A.
June 4, 2026 8:58 AM - SEC Filing
Form 8-A12B Banco Santander, S.A.
June 4, 2026 6:51 AM - SEC Filing
Form 6-K Banco Santander, S.A. For: Jun 04
June 4, 2026 6:09 AM - SEC Filing
Press Release: Sanofi launches 2026 global employee stock purchase plan
June 4, 2026 4:07 AM - Globe NewsWire
Euro area loan growth edges up in April on stronger corporate lending
June 1, 2026 6:00 AM - StreetInsider
Form 6-K BANCO SANTANDER CHILE For: May 28
May 29, 2026 6:02 AM - SEC Filing
Form 424B5 Banco Santander, S.A.
May 28, 2026 12:54 PM - SEC Filing
Form SD Sanofi
May 28, 2026 6:07 AM - SEC Filing
Form 6-K Banco Santander, S.A. For: May 27
May 28, 2026 6:02 AM - SEC Filing
Form FWP Banco Santander, S.A. Filed by: Banco Santander, S.A.
May 27, 2026 5:26 PM - SEC Filing
Form 6-K Sanofi For: May 27
May 27, 2026 10:32 AM - SEC Filing
Form SC TO-I Banco Santander, S.A. Filed by: Banco Santander, S.A.
May 27, 2026 6:15 AM - SEC Filing
Form 424B5 Banco Santander, S.A.
May 27, 2026 6:09 AM - SEC Filing
Form 6-K Banco Santander, S.A. For: May 27
May 27, 2026 6:09 AM - SEC Filing
Form 6-K Banco Santander, S.A. For: May 27
May 27, 2026 6:04 AM - SEC Filing
Webster Financial shareholders approve $12 billion Santander takeover
May 26, 2026 12:51 PM - StreetInsider
Sanofi reports positive phase 2 trial results for AATD treatment
May 18, 2026 3:30 PM - StreetInsider
Press Release: ATS: phase 2 data demonstrate the superiority of efdoralprin alfa over a standard-of-care augmentation therapy in achieving higher fAAT levels in AATD
May 18, 2026 3:30 PM - Globe NewsWire
Banco Santander SA (SAN:SM) (SAN) PT Raised to EUR12 at Jefferies
May 14, 2026 4:13 AM - StreetInsider
Form 6-K BANCO SANTANDER CHILE For: Apr 30
May 13, 2026 5:21 PM - SEC Filing
Santander US Survey Finds Resilient Consumers in Need of Vehicles, Used-Car Demand Persists
May 13, 2026 12:07 PM - BizWire
Form 6-K Banco Santander, S.A. For: May 13
May 13, 2026 10:06 AM - SEC Filing
Banco Santander SA (SAN:SM) (SAN) PT Raised to EUR12.75 at RBC Capital
May 12, 2026 2:00 AM - StreetInsider
Form 6-K BANCO SANTANDER CHILE For: Mar 31
May 11, 2026 4:26 PM - SEC Filing
Form 6-K BANCO SANTANDER CHILE For: May 11
May 11, 2026 2:43 PM - SEC Filing
Form 13F-HR Banco Santander, S.A. For: Mar 31
May 8, 2026 6:13 AM - SEC Filing
Form 13F-HR Sanofi For: Mar 31
May 7, 2026 8:47 AM - SEC Filing
Sanofi Supports AlphaDetect to Accelerate Detection of Alpha-1
May 6, 2026 12:42 PM - PR NewsWire
Form 6-K BANCO SANTANDER CHILE For: May 05
May 6, 2026 6:02 AM - SEC Filing
Form 6-K Sanofi For: May 05
May 5, 2026 6:08 AM - SEC Filing
Banco Santander SA (SAN:SM) (SAN) PT Raised to EUR12.10 at Deutsche Bank
May 5, 2026 5:25 AM - StreetInsider
Banco Santander SA (SAN:SM) (SAN) PT Lowered to EUR12.10 at Kepler Cheuvreux
May 5, 2026 5:21 AM - StreetInsider
Form 6-K Banco Santander, S.A. For: May 01
May 1, 2026 9:31 AM - SEC Filing
Form 6-K Santander UK plc For: May 01
May 1, 2026 9:21 AM - SEC Filing
Form 6-K BANCO SANTANDER CHILE For: Mar 31
April 30, 2026 3:58 PM - SEC Filing
Banco Santander-Chile Announces First Quarter 2026 Earnings
April 30, 2026 8:01 AM - Globe NewsWire
Banco Santander SA (SAN:SM) (SAN) PT Raised to EUR12.70 at UBS
April 30, 2026 6:18 AM - StreetInsider
Form 6-K BANCO SANTANDER CHILE For: Apr 29
April 30, 2026 6:01 AM - SEC Filing
Banco Santander SA (SAN:SM) (SAN) PT Raised to EUR12.90 at Barclays
April 30, 2026 5:45 AM - StreetInsider
Form 6-K Banco Santander, S.A. For: Mar 31
April 29, 2026 4:12 PM - SEC Filing
Sanofi names Belén Garijo as CEO following shareholder approval
April 29, 2026 12:00 PM - StreetInsider
Press Release: Annual General Meeting of April 29, 2026 - Belén Garijo appointed as Director and Chief Executive Officer of Sanofi
April 29, 2026 12:00 PM - Globe NewsWire
Form 6-K Banco Santander, S.A. For: Mar 31
April 29, 2026 6:14 AM - SEC Filing
Form 6-K Banco Santander, S.A. For: Mar 31
April 29, 2026 6:12 AM - SEC Filing
Form 6-K Sanofi For: Apr 29
April 29, 2026 6:11 AM - SEC Filing
Form 6-K Banco Santander, S.A. For: Mar 31
April 29, 2026 6:10 AM - SEC Filing
Form 6-K Sanofi For: Apr 27
April 27, 2026 12:58 PM - SEC Filing
Form 6-K BANCO SANTANDER CHILE For: Apr 23
April 24, 2026 9:13 AM - SEC Filing
Form 6-K Banco Santander, S.A. For: Apr 24
April 24, 2026 6:28 AM - SEC Filing
Sanofi drug gets EU panel backing for progressive multiple sclerosis
April 24, 2026 6:10 AM - StreetInsider
Press Release: Sanofi’s Cenrifki (tolebrutinib) recommended for EU approval by the CHMP to treat secondary progressive multiple sclerosis without relapses
April 24, 2026 6:09 AM - Globe NewsWire
Form 424B3 Banco Santander, S.A.
April 23, 2026 7:07 PM - SEC Filing
Form 6-K Sanofi For: Mar 31
April 23, 2026 7:20 AM - SEC Filing
Form 6-K Banco Santander, S.A. For: Apr 23
April 23, 2026 6:09 AM - SEC Filing
Form EFFECT Banco Santander, S.A.
April 23, 2026 6:05 AM - SEC Filing
Form 6-K Banco Santander, S.A. For: Apr 23
April 23, 2026 6:05 AM - SEC Filing
Press Release: Q1 2026: double-digit sales and business EPS growth
April 23, 2026 1:41 AM - Globe NewsWire
Form 6-K Banco Santander, S.A. For: Apr 22
April 22, 2026 6:16 AM - SEC Filing
FDA approves Sanofi's Tzield for children as young as one year old
April 22, 2026 1:09 AM - StreetInsider
Press Release: Sanofi's Tzield approved in the US to delay the onset of stage 3 type 1 diabetes in young children
April 22, 2026 1:05 AM - Globe NewsWire
Form ABS-15G Santander UK plc For: Apr 20
April 20, 2026 5:12 PM - SEC Filing
Form F-4/A Banco Santander, S.A.
April 20, 2026 3:48 PM - SEC Filing
Press Release: ESCMID: Sanofi's Nuvaxovid COVID-19 vaccine showed better tolerability than mNEXSPIKE in head-to-head study
April 18, 2026 6:00 AM - Globe NewsWire
Form CERT Banco Santander, S.A.
April 17, 2026 11:08 AM - SEC Filing
Form 8-A12B Banco Santander, S.A.
April 17, 2026 10:57 AM - SEC Filing
Form 6-K BANCO SANTANDER CHILE For: Apr 16
April 16, 2026 9:28 AM - SEC Filing
Form 6-K Banco Santander, S.A. For: Apr 16
April 16, 2026 6:17 AM - SEC Filing
Form 6-K Banco Santander, S.A. For: Apr 15
April 15, 2026 4:15 PM - SEC Filing
Americans Determined to Grow Savings with Tax Refunds, Santander Bank Survey Finds
April 15, 2026 10:23 AM - BizWire
Form 6-K Sanofi For: Apr 15
April 15, 2026 6:57 AM - SEC Filing
Form 6-K Banco Santander, S.A. For: Apr 14
April 14, 2026 12:09 PM - SEC Filing
Form 6-K BANCO SANTANDER CHILE For: Apr 13
April 14, 2026 8:33 AM - SEC Filing
Banco Santander SA (SAN:SM) (SAN) PT Raised to EUR12 at Jefferies
April 14, 2026 2:43 AM - StreetInsider
Form 6-K BANCO SANTANDER CHILE For: Mar 31
April 13, 2026 5:26 PM - SEC Filing
Form SCHEDULE 13G/A Sanofi Filed by: Amundi
April 10, 2026 9:58 AM - SEC Filing
Form 424B5 Banco Santander, S.A.
April 9, 2026 3:23 PM - SEC Filing
Form FWP Banco Santander, S.A. Filed by: Banco Santander, S.A.
April 9, 2026 6:03 AM - SEC Filing
Form 424B5 Banco Santander, S.A.
April 8, 2026 8:12 AM - SEC Filing
Form 6-K Banco Santander, S.A. For: Apr 08
April 8, 2026 6:16 AM - SEC Filing
Form 425 Banco Santander, S.A. Filed by: Banco Santander, S.A.
April 7, 2026 3:23 PM - SEC Filing
Sanofi's lunsekimig meets goals in asthma, nasal polyps studies
April 7, 2026 1:01 AM - StreetInsider
Press Release: Sanofi’s lunsekimig met primary and key secondary endpoints in phase 2 respiratory studies in asthma and CRSwNP
April 7, 2026 1:01 AM - Globe NewsWire
Form 6-K Banco Santander, S.A. For: Dec 31
April 1, 2026 4:08 PM - SEC Filing
Form 6-K BANCO SANTANDER CHILE For: Mar 31
March 31, 2026 2:52 PM - SEC Filing
Form 6-K Sanofi For: Mar 31
March 31, 2026 12:19 PM - SEC Filing
Banco Santander Chile: First Quarter 2026 Analyst and Investor Webcast / Conference Call
March 31, 2026 10:55 AM - Globe NewsWire
Sanofi's amlitelimab shows positive results in atopic dermatitis trials
March 28, 2026 11:00 AM - StreetInsider
Press Release: AAD: new results from Sanofi's amlitelimab phase 3 studies in atopic dermatitis presented in late-breaking research session
March 28, 2026 11:00 AM - Globe NewsWire
Form 6-K Banco Santander, S.A. For: Mar 27
March 27, 2026 10:54 AM - SEC Filing
Form 6-K Banco Santander, S.A. For: Mar 27
March 27, 2026 6:07 AM - SEC Filing
Form 6-K Banco Santander, S.A. For: Mar 26
March 26, 2026 6:18 AM - SEC Filing
Form 25-NSE Banco Santander, S.A. Filed by: NEW YORK STOCK EXCHANGE LLC
March 25, 2026 2:44 PM - SEC Filing
Form 6-K BANCO SANTANDER CHILE For: Mar 24
March 24, 2026 5:01 PM - SEC Filing
Form 6-K Sanofi For: Mar 24
March 24, 2026 11:57 AM - SEC Filing
Morgan Stanley Upgrades Banco Santander SA (SAN:SM) (SAN) to Overweight
March 23, 2026 6:12 AM - StreetInsider
Form 6-K Banco Santander, S.A. For: Mar 19
March 19, 2026 7:38 AM - SEC Filing
Form 144 Banco Santander, S.A. Filed by: Hazell David Arthur
March 13, 2026 10:28 AM - SEC Filing
Form F-N Banco Santander, S.A. Filed by: Banco Santander, S.A.
March 12, 2026 3:42 PM - SEC Filing
Form IRANNOTICE Santander UK plc
March 12, 2026 3:42 PM - SEC Filing
Form 20-F Santander UK plc For: Dec 31
March 12, 2026 3:42 PM - SEC Filing
Form F-4 Banco Santander, S.A.
March 12, 2026 3:21 PM - SEC Filing
Form 6-K Banco Santander, S.A. For: Mar 12
March 12, 2026 7:22 AM - SEC Filing
Form 6-K BANCO SANTANDER CHILE For: Mar 11
March 12, 2026 6:03 AM - SEC Filing
Form 6-K BANCO SANTANDER CHILE For: Feb 28
March 12, 2026 6:02 AM - SEC Filing
Form 6-K Sanofi For: Mar 10
March 10, 2026 10:41 AM - SEC Filing
Form 6-K BANCO SANTANDER CHILE For: Mar 09
March 9, 2026 4:16 PM - SEC Filing
Full Article List
